B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor.
about
Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogenesisRisk of non-Hodgkin lymphoma in association with germline variation in complement genesCustomized oligonucleotide array-based comparative genomic hybridization as a clinical assay for genomic profiling of chronic lymphocytic leukemiaRole of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell NeoplasmsIbrutinib (PCI-32765) in chronic lymphocytic leukemiaImmunological aspects in chronic lymphocytic leukemia (CLL) developmentThe pathogenesis of chronic lymphocytic leukemiaExtensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples.Second-generation inhibitors of Bruton tyrosine kinaseAn open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemiaZAP-70 in B cell malignanciesFunctional and prognostic role of ZAP-70 in chronic lymphocytic leukaemiaRegulation of CD23 expression by Notch2 in B-cell chronic lymphocytic leukemiaEndothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through ETA receptorCD47 agonist peptides induce programmed cell death in refractory chronic lymphocytic leukemia B cells via PLCĪ³1 activation: evidence from mice and humansRemarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemiaStereotypical chronic lymphocytic leukemia B-cell receptors recognize survival promoting antigens on stromal cells.Analysis of VH gene sequences using two web-based immunogenetics resources gives different results, but the affinity maturation status of chronic lymphocytic leukaemia clones as assessed from either of the resulting data sets has no prognostic signiCellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities.Chronic lymphocytic leukemia and autoimmunity: a systematic review.Toll-like receptors on B-CLL cells: expression and functional consequences of their stimulation.Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells.B1 lymphocytes and myeloid dendritic cells in lymphoid organs are preferential extratumoral sites of parvovirus minute virus of mice prototype strain expression.Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity.Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of originB-cell receptor epitope recognition correlates with the clinical course of chronic lymphocytic leukemia.Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignancies.The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo.Immunoglobulin heavy- and light-chain repertoire in splenic marginal zone lymphomaViability and stress protection of chronic lymphoid leukemia cells involves overactivation of mitochondrial phosphoSTAT3Ser727.The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemiaPeptides that bind specifically to an antibody from a chronic lymphocytic leukemia clone expressing unmutated immunoglobulin variable region genes.Intraclonal cell expansion and selection driven by B cell receptor in chronic lymphocytic leukemia.The Role of CD44 in the Pathophysiology of Chronic Lymphocytic Leukemia.Somatic hypermutation patterns in germinal center B cell malignancies.Anti-idiotype vaccines.Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia.Similarities and differences between the light and heavy chain Ig variable region gene repertoires in chronic lymphocytic leukemia.Rewiring of sIgM-mediated intracellular signaling through the CD180 Toll-like receptor.
P2860
Q23917829-FB0CAA85-1CC3-4B2B-9098-E58A51FC03D1Q24648778-3FD8218D-9B1E-4BE5-86A6-4BCF1294C641Q24657747-F818E2EA-5BD3-445F-881D-1390683F78FEQ26795594-00892013-5ADD-4D4A-85EC-D41768D4A9FBQ26852328-063EA164-24CF-48EF-9740-8778F2F0A886Q26865940-0BE4FA1D-59B4-4CB1-BDE9-245410A6E905Q27025715-F4C060C3-696D-49FC-89CB-3216A5CDDC6FQ27303212-F843423D-D7F3-4FDF-B15F-836E75501ABCQ28076118-2D9A6A4C-B14C-485E-908E-A1BE5F2DD0A4Q28257366-9417C8A4-E84F-4031-B3DB-6A5134AD11BAQ28279902-9A75AF86-2AB0-49FC-8F85-122C498662F1Q28282822-BC080852-C110-46E4-881C-8F261E4CDFFAQ28300257-068E51FA-71FC-4C25-B95C-B8E69C705AA4Q28539394-8E486739-D28A-46F3-8C10-97F949D44BCAQ28543785-56E1DAF6-BCDC-4E4A-A43B-1DFA5101F564Q29048141-53AF5FCE-83B8-46FC-A096-06CF3A11A6DFQ30994095-37BCC4BB-9A27-4E9D-A417-4860898F80F7Q33212981-51864254-B55E-4A6E-BAE9-DA2B9965DCC4Q33350258-75DB2EC2-6C2C-4355-9EC3-ACE32F782461Q33393696-E344A9E0-D0F0-4D33-8938-E0BEA615FF95Q33494116-2B82068C-1F98-4F7B-822A-F69D3ADDBA67Q33494799-4D884F51-A4C8-4891-8931-2BADE4EC97ADQ33737706-FFB6FD57-7F7C-415D-BD4F-A81B518D5594Q33771413-1989A2E7-EEB3-45CF-B410-7868BB0A2A92Q33849548-7FA095B5-6B55-4DA5-A0EB-B8FAAA8BA9B4Q33878649-FEA27509-B2A1-4DF3-84A4-DFF3F967BE50Q33893704-7DD5915C-2B9A-4766-AD79-34A4B44EDEC8Q34029869-E4EA1907-C963-4A77-B97C-4A4399EBEFE9Q34521334-9A11E2EF-99F7-4173-9112-A2F6CC976C17Q34541525-15805ED6-4C50-472A-A772-9DC3AA526C37Q34542102-FB64A98B-4BD9-4BC9-9999-7592CAABAF3AQ34830865-21B13357-BD9B-4B48-99B6-8BD06D02C109Q34901206-BCE0AF73-E602-4710-BA6D-6E175FF8EA36Q35136742-C53F12B9-84C1-44D9-BA67-1E7993B889F8Q35489417-8B1EDAD3-A555-43D1-82BA-5A4734A7AD2CQ35552528-FC29B04D-D67E-4E69-9756-538B1640279FQ35591089-0D352CD7-EF9F-4F6D-87C8-F86682CFEDC4Q35642807-186EBC1A-8C46-4C4E-97FB-92DEE047CDAFQ35690880-C257CDF7-037C-4C99-9EF1-3D9D7CD2C1C3Q35707093-A2258077-F7C8-436E-8B11-B8A399CD1F9D
P2860
B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor.
description
2001 nĆ® lÅ«n-bĆ»n
@nan
2001 Õ©ÕøÖÕ”ÕÆÕ”Õ¶Õ« Ō“Õ„ÕÆÕæÕ„Õ“Õ¢Õ„ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕøÖÕ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ ÕµÖ
Õ¤ÕøÖÕ”Õ®
@hyw
2001 Õ©Õ¾Õ”ÕÆÕ”Õ¶Õ« Õ¤Õ„ÕÆÕæÕ„Õ“Õ¢Õ„ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕ¾Õ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ Õ°ÕøÕ¤Õ¾Õ”Õ®
@hy
2001幓ć®č«ę
@ja
2001幓č«ę
@yue
2001幓č«ę
@zh-hant
2001幓č«ę
@zh-hk
2001幓č«ę
@zh-mo
2001幓č«ę
@zh-tw
2001幓č®ŗę
@wuu
name
B cell chronic lymphocytic leu ...... f the B cell antigen receptor.
@ast
B cell chronic lymphocytic leu ...... f the B cell antigen receptor.
@en
type
label
B cell chronic lymphocytic leu ...... f the B cell antigen receptor.
@ast
B cell chronic lymphocytic leu ...... f the B cell antigen receptor.
@en
prefLabel
B cell chronic lymphocytic leu ...... f the B cell antigen receptor.
@ast
B cell chronic lymphocytic leu ...... f the B cell antigen receptor.
@en
P1476
B cell chronic lymphocytic leu ...... f the B cell antigen receptor.
@en
P2093
Manlio Ferrarini
Nicholas Chiorazzi
P304
P356
10.1146/ANNUREV.IMMUNOL.21.120601.141018
P577
2001-12-19T00:00:00Z